Depsipeptide (FR901228): A novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells

John C. Byrd, Charlotte Shinn, Rajani Ravi, Carl R. Willis, Jamie K. Waselenko, Ian W. Flinn, Nancy A. Dawson, Michael R. Grever

Research output: Contribution to journal › Article › peer-review

149 Scopus citations

Fingerprint

Dive into the research topics of 'Depsipeptide (FR901228): A novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds